Literature DB >> 15021950

[Angiogenesis investigations in tissue engineering. The cylinder model on the chorioallantois membrane].

J Borges1, F T Tegtmeier, N Torio-Padron, M C Mueller, G B Stark.   

Abstract

INTRODUCTION: Tissue engineering (TE) applications include the isolation, culture, and seeding of cells into a suitable matrix or scaffold prior to in vivo transplantation. After transplantation, vascularization of the scaffold is a principal factor limiting cell viability for the first 6-8 days post transplantation. A model has been developed for systematic analysis of this process.
METHODS: Fertilized white Leghorn eggs were incubated and opened at day 3 of incubation. Preadipocyte-seeded fibrin constructs were implanted in a specially designed plastic cylinder and placed through the opening onto the surface of the chorioallantoic membrane (CAM) at day 8 of incubation. Vascularization of the constructs by chorioallantoic blood vessels was assessed for up to 8 days post transplantation.
RESULTS: The survival rate for embryos receiving constructs was about 90%. Histology confirmed transplant cell viability at day 4 post transplantation, and vascularization of the constructs by avian endothelial cells progressively increased thereafter.
CONCLUSION: A new in vivo model to study the effect of angiogenesis in TE constructs including assessments of viability, proliferation, and differentiation of transplanted cells and biomaterial properties is presented. Advantages include easy access to the CAM vascular network, lack of immunocompetence, low cost, and avoidance of animal experiments.

Mesh:

Year:  2004        PMID: 15021950     DOI: 10.1007/s00104-003-0770-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  23 in total

1.  The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium.

Authors:  J W Maas; F A Le Noble; G A Dunselman; A F de Goeij; H A Struyker Boudier; J L Evers
Journal:  Gynecol Obstet Invest       Date:  1999       Impact factor: 2.031

2.  Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

3.  Angiogenesis is associated with collagenous protein synthesis and degradation in the chick chorioallantoic membrane.

Authors:  E Missirlis; G Karakiulakis; M E Maragoudakis
Journal:  Tissue Cell       Date:  1990       Impact factor: 2.466

4.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

5.  Rate of basement membrane biosynthesis as an index to angiogenesis.

Authors:  M E Maragoudakis; M Panoutsacopoulou; M Sarmonika
Journal:  Tissue Cell       Date:  1988       Impact factor: 2.466

Review 6.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

7.  Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Dev Biol       Date:  1974-06       Impact factor: 3.582

8.  Exogenous heparin induces fibronectin overexpression parallel to angiogenesis in the extracellular matrix of the chick embryo chorioallantoic membrane.

Authors:  D Ribatti; A Vacca; F Costantino; M Minischetti; P Locci; E Becchetti; L Roncali; F Dammacco
Journal:  Tissue Cell       Date:  1997-04       Impact factor: 2.466

9.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.

Authors:  J Wilting; B Christ; M Bokeloh; H A Weich
Journal:  Cell Tissue Res       Date:  1993-10       Impact factor: 5.249

10.  Effects of vascular endothelial growth factor and basic fibroblast growth factor: application with corneal grafts on the chorioallantoic membrane.

Authors:  J Wilting; H A Weich; B Christ
Journal:  Acta Anat (Basel)       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.